Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Van Veen

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Proceedings of the National Academy of Sciences of the United States of America|November 24, 2020
ATP13A2-mediated endo-lysosomal polyamine export counters mitochondrial oxidative stressStephanie Vrijsen, Laura Besora-Casals, Sarah van Veen, et al.
Nature|January 31, 2020
ATP13A2 deficiency disrupts lysosomal polyamine exportSarah van Veen, Shaun Martin, Chris Van den Haute, et al.
Acta Neuropathologica|March 16, 2020
Mutated ATP10B increases Parkinson's disease risk by compromising lysosomal glucosylceramide exportShaun Martin, Stefanie Smolders, Chris Van den Haute, et al.
Brain : a Journal of Neurology|February 1, 2017
Loss-of-function mutations in the ATP13A2/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78)Alejandro Estrada-Cuzcano, Shaun Martin, Teodora Chamova, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Proceedings of the National Academy of Sciences of the United States of America|November 24, 2020
ATP13A2-mediated endo-lysosomal polyamine export counters mitochondrial oxidative stressStephanie Vrijsen, Laura Besora-Casals, Sarah van Veen, et al.
Nature|January 31, 2020
ATP13A2 deficiency disrupts lysosomal polyamine exportSarah van Veen, Shaun Martin, Chris Van den Haute, et al.
Acta Neuropathologica|March 16, 2020
Mutated ATP10B increases Parkinson's disease risk by compromising lysosomal glucosylceramide exportShaun Martin, Stefanie Smolders, Chris Van den Haute, et al.
Brain : a Journal of Neurology|February 1, 2017
Loss-of-function mutations in the ATP13A2/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78)Alejandro Estrada-Cuzcano, Shaun Martin, Teodora Chamova, et al.
Pageof 2